Arsenic exposure, μg/L | Carriers of the class S allele | Non-carriers of the class S allele | ||||
---|---|---|---|---|---|---|
Controls n (%) | Patients n (%) | Multivariate-adjusted OR (95% CI) | Controls n (%) | Patients n (%) | Multivariate-adjusted OR (95% CI) | |
Lanyang cohort a | Â | Â | Â | Â | Â | Â |
   ≤ 10 | 13 (6.8) | 7 (3.9) | 1.0 (referent) | 5 (7.7) | 2 (2.8) | 1.0 (referent) |
   10.1-50 | 7 (3.7) | 5 (2.8) | 1.57 (0.33-7.38) | 3 (4.6) | 4 (5.6) | 8.64 (0.70-106.82) |
   50.1-100 | 66 (34.6) | 64 (36.0) | 2.90 (1.02-8.27)* | 21 (32.3) | 24 (33.3) | 4.04 (0.64-25.76) |
   100.1-300 | 60 (31.4) | 61 (34.3) | 2.90 (1.00-8.35)* | 19 (29.2) | 20 (27.8) | 4.47 (0.69-29.19) |
   > 300 | 45 (23.6) | 41 (23.0) | 2.39 (0.81-7.05) | 17 (26.2) | 22 (30.6) | 3.97 (0.62-25.57) |
   Trend test |  |  | 1.12 (0.91-1.38) |  |  | 1.13 (0.81-1.57) |
LMN cohort b | Â | Â | Â | Â | Â | Â |
   ≤ 300 | 39 (32.8) | 10 (12.4) | 1.0 (referent) | 13 (28.9) | 2 (5.6) | 1.0 (referent) |
   300-750 | 43 (36.1) | 36 (44.4) | 2.04 (0.75-5.57) | 22 (48.9) | 20 (55.6) | 1.13 (0.16-7.95) |
   > 750 | 37 (31.1) | 35 (43.2) | 2.20 (0.79-6.10) | 10 (22.2) | 14 (38.9) | 4.65 (0.66-32.94) |
   Trend test |  |  | 1.39 (0.86-2.25) |  |  | 2.65 (1.03-6.82)* |